NCT05902221View on ClinicalTrials.gov

Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Infections Joint Prosthetic
Interventions
DRUG

amoxicillin or moxifloxacin

Antibiotic treatment back bone during 12 weeks

DRUG

amoxicillin or moxifloxacin + rifampicin

Antibiotic treatment back bone during 12 weeks + rifampicin

Trial Locations (12)

Unknown

CH Annecy Genevois, Annecy

CHU de BORDEAUX, Bordeaux

HCL, Lyon

AP-HM, Marseille

CHU de MONTPELLIER, Montpellier

CHU de Nantes, Nantes

Dianonesses croix saint simon, Paris

CHU de Rennes, Rennes

CHU Toulouse, Toulouse

Ch Tourcoing, Tourcoing

CHRU Tours, Tours

06200

CHU de NICE, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER